Drug Research
Sun Pharma rolls out first ready to administer anti cancer drug in six European countries
Sun Pharma, India's largest drug company has rolled out InfuSMART the first ever ready to administer version of anti cancer drug gemcitabine in six countries...
Articles
The Anti-Counterfeit Drug Issue; It’s Real
Legislation is being put into place, but it is still essential that we all play a participative role in the continued fight to protect the...
Articles
Fighting Cancer with targeted Drugs
“Diagnosis cancer” – this is a life-changing moment for many people. After cardiovascular diseases, cancer remains the next most common cause of death worldwide. In...
Drug Research
Takeda Pharmaceutical Company Licenses Global Rights to Theravance Biopharma’s TD-8954
Takeda and Theravance Biopharma, Inc. announced that the companies have entered into a global license, development and commercialization agreement for TD-8954, a selective 5-HT4 receptor...
Drug Research
GSKs Bexsero achieves primary and secondary endpoints with reduced 3-dose schedule in safety and immunogenicity study in infants and children
GSK presented new data for its meningococcal group B vaccine, Bexsero®,1 comparing safety and immunogenicity with different dosing schedules in infants and young children,...
Drug Research
Nplate Study In The Lancet Shows Significant Increase In Durable Platelet Response Among Children With Immune Thrombocytopenia
Amgen announced that The Lancet published results from a Phase 3 randomized, double-blind, placebo-controlled study of Nplate in children with symptomatic immune thrombocytopenia. ...
Drug Research
Amgen Astellas Biopharma and Astellas Introduce new treatment option for the high cholesterol patients
FIrst PCSK9 Inhibitor in Japan,Providing A new TREATMENT option for certain patients who have high risk in cardiovascular events and do not adequately respond...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.